Published in Pathol Res Pract on April 01, 1990
Cytotoxicity of streptozotocin on neuroendocrine cells of the pancreas and the gut. Dig Dis Sci (2003) 0.91
The role of peptide YY in gastrointestinal diseases and disorders (review). Int J Mol Med (2012) 0.90
Gastrointestinal endocrine cells in an animal model for human type 2 diabetes. Dig Dis Sci (1999) 0.80
Supplementation with L-Glutamine and L-Alanyl-L-Glutamine Changes Biochemical Parameters and Jejunum Morphophysiology in Type 1 Diabetic Wistar Rats. PLoS One (2015) 0.77
Antral endocrine cells in nonobese diabetic mice. Dig Dis Sci (1998) 0.75
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30
Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med (1998) 5.66
The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81
Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci U S A (1987) 4.53
High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA (1992) 4.31
A silver nitrate stain for alpha-2 cells in human pancreatic islets. Acta Soc Med Ups (1968) 3.93
Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. JAMA (1997) 3.80
Stressful life events and Graves' disease. Lancet (1991) 3.63
Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31
Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13
Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J Natl Cancer Inst (1998) 3.10
Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst (1996) 2.71
Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64
The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58
Strategies for global control of cervical cancer. Int J Cancer (1995) 2.52
Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol (1997) 2.46
Increasing cancer risk in younger birth cohorts in Sweden. Lancet (1993) 2.39
Testicular cancer in nine northern European countries. Int J Cancer (1994) 2.32
The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus. Diabetologia (1978) 2.31
A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun (1986) 2.24
No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16
Survival in breast cancer diagnosed between mammographic screening examinations. Lancet (1986) 2.12
Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestogen replacement therapy. Am J Epidemiol (1989) 2.07
Response rate to mailed epidemiologic questionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol (1998) 2.06
Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet (1975) 2.04
Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst (1997) 1.98
Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy. Int J Cancer (1999) 1.98
Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med (1998) 1.91
Observed and relative survival after aortic valve replacement. J Am Coll Cardiol (2000) 1.86
Body size in different periods of life and breast cancer risk in post-menopausal women. Int J Cancer (1998) 1.86
Histopathological classification of nonantral gastric endocrine growths in man. Digestion (1988) 1.85
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med (2000) 1.83
Increasing survival trend after cancer diagnosis in Sweden: 1960-1984. J Natl Cancer Inst (1989) 1.82
Surgical anatomy of human parathyroid glands. Surgery (1984) 1.81
Oral contraceptive use and breast cancer in young women. A joint national case-control study in Sweden and Norway. Lancet (1986) 1.79
Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med (1986) 1.79
Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet (1998) 1.78
Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun (1989) 1.77
Identification of tryptophan hydroxylase as an intestinal autoantigen. Lancet (1998) 1.77
Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res (1998) 1.75
Risk factors for oesophageal cancer in northeast China. Int J Cancer (1994) 1.73
Risk of endometrial cancer following estrogen replacement with and without progestins. J Natl Cancer Inst (1999) 1.73
Smoking and colorectal cancer: a 20-year follow-up study of Swedish construction workers. J Natl Cancer Inst (1996) 1.71
Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J (2000) 1.68
Sternal wound complications--incidence, microbiology and risk factors. Eur J Cardiothorac Surg (1997) 1.66
Co-localization of islet amyloid polypeptide and insulin in the B cell secretory granules of the human pancreatic islets. Diabetologia (1989) 1.66
Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet (1999) 1.61
The potential of the immunogold-silver staining method for paraffin sections. Histochemistry (1984) 1.60
Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol (1996) 1.59
Mammographic screening for breast cancer. What cancers do we find? Eur J Cancer (1997) 1.58
Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979. Surgery (1987) 1.56
Estimation of the parenchymal-cell content of the parathyroid gland, using density-gradient columns. Preliminary report. Acta Pathol Microbiol Scand A (1977) 1.52
Anaplastic thyroid carcinoma: three protocols combining doxorubicin, hyperfractionated radiotherapy and surgery. Br J Cancer (2002) 1.51
International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer (1997) 1.50
Relationship between questionnaire data and medical records of height, weight and body mass index. Int J Obes Relat Metab Disord (1992) 1.49
Papanicolaou smear screening and cervical cancer. What can you expect? JAMA (1984) 1.48
The role of human papillomavirus in cervical adenocarcinoma carcinogenesis. Eur J Cancer (2001) 1.48
Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int (1993) 1.48
Human fertility does not decline: evidence from Sweden. Fertil Steril (1999) 1.47
Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab (1992) 1.47
The effect of female sex hormones on cancer survival. A register-based study in patients younger than 20 years at diagnosis. JAMA (1990) 1.45
Long-term trends in incidence of and mortality from acute myocardial infarction and stroke in women: Analyses of total first events and of deaths in the Uppsala Health Care Region, Sweden. Epidemiology (1996) 1.45
Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Cancer Res (1993) 1.45
Screening for osteopenia and osteoporosis: selection by body composition. Osteoporos Int (1996) 1.45
Amyloid in polypeptide hormone-producing tumors. Lab Invest (1977) 1.45
The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults. Acta Pathol Microbiol Scand A (1973) 1.43
Survival and renal function in untreated hypercalcaemia. Population-based cohort study with 14 years of follow-up. Lancet (1987) 1.42
Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol (1975) 1.41
Malignant carcinoid tumors. An analysis of 103 patients with regard to tumor localization, hormone production, and survival. Ann Surg (1987) 1.41
Melanoma in pregnancy. Lancet (1991) 1.39
Oncocytic tumor of the pancreas. Report of a case with aspiration cytology. Acta Cytol (1990) 1.39
Normocalcemic hyperparathyroidism, kidney stones, and idiopathic hypercalciuria. Surgery (1975) 1.38
Mammographic parenchymal patterns in women receiving noncontraceptive estrogen treatment. Am J Epidemiol (1989) 1.38
Self-sampling of the vaginal fluid at home combined with high-risk HPV testing. Br J Cancer (2009) 1.36
Colonic endocrine cells in inflammatory bowel disease. J Intern Med (1997) 1.35
Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. Int J Cancer (1999) 1.33
The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement. Br J Obstet Gynaecol (1992) 1.32
Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease. Am J Pathol (1993) 1.30
High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. Br J Cancer (2005) 1.29
Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement. Cancer Causes Control (1999) 1.28
Medical treatment and long-term survival in a prospective study of 84 patients with endocrine pancreatic tumors. Cancer (1990) 1.28
Silver stains in the study of endocrine cells of the gut and pancreas. Invest Cell Pathol (1980) 1.27
Natural history of localised prostatic cancer. A population-based study in 223 untreated patients. Lancet (1989) 1.26
Nutrients and gastric cancer risk. A population-based case-control study in Sweden. Int J Cancer (1994) 1.25
Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol (1993) 1.25
Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer (1996) 1.24
Age at first primary as a determinant of the incidence of bilateral breast cancer. Cumulative and relative risks in a population-based case-control study. Cancer (1985) 1.23
Trends in thyroid cancer incidence in Sweden, 1958-1981, by histopathologic type. Int J Cancer (1991) 1.23
Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material. Virchows Arch A Pathol Anat Histol (1975) 1.22
A prospective study of association of monounsaturated fat and other types of fat with risk of breast cancer. Arch Intern Med (1998) 1.22
The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker". Pathol Res Pract (1989) 1.21
Early life risk factors for prostate cancer: a population-based case-control study in Sweden. Cancer Epidemiol Biomarkers Prev (1995) 1.20
Absence of association between reproductive variables and the risk of breast cancer in young women in Sweden and Norway. Br J Cancer (1990) 1.20
Nuclear DNA-content of parathyroid cells in adenomas, hyperplastic and normal glands. Acta Pathol Microbiol Scand A (1977) 1.20
Fertility patterns after appendicectomy: historical cohort study. BMJ (1999) 1.19
Identification of the intestinal cell storing gastric inhibitory peptide. Histochemistry (1975) 1.19
Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg (1992) 1.19
Islet amyloid polypeptide (IAPP):cDNA cloning and identification of an amyloidogenic region associated with the species-specific occurrence of age-related diabetes mellitus. Exp Cell Res (1989) 1.19